On Thursday, December 18, 2014 the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee will meet in mostly closed session. The meeting will be closed to permit discussion of whether FDA should permit further clinical development of an existing investigational drug product, which will include the review of trade secret and/ or confidential information. From 8:30 a. m. to 9:45 a.m., the meeting is open to the public. Because this meeting is mostly a closed session, Tarius will not cover this meeting.